American Society of Hematology

SHERPA: Blue

People

  1. Tamari
    Tamari
  2. Giralt
    Giralt
  3. Perales
    Perales
  4. Papadopoulos
    Papadopoulos
  5. Jakubowski
    Jakubowski
  6. Devlin
    Devlin
  7. Shaffer
    Shaffer
  8. Ponce
    Ponce
  9. Castro-Malaspina
    Castro-Malaspina
  10. Dahi
    Dahi

Groups

  1. Bone Marrow Transplant (66)
  2. CTCR Scholars (66)
  3. Center for Hematologic Malignancies (66)
  4. Department of Medicine (66)
  5. Hematologic Malignancies, Division of (66)
  6. MSK Grad Students (66)
  7. Master of Science in Clinical and Translational Cancer Research (66)
  8. Survivorship Research (48)
  9. Biostatistics Service (36)
  10. Epidemiology and Biostatistics (36)
Search Within
  1. "Roni Tamari"
Formats
  1. Meeting Abstract (53)
  2. Journal Article (12)
  3. Research Letter (1)
Groups
  1. Bone Marrow Transplant (66)
  2. CTCR Scholars (66)
  3. Center for Hematologic Malignancies (66)
  4. Department of Medicine (66)
  5. Hematologic Malignancies, Division of (66)
  6. MSK Grad Students (66)

More Groups

People
  1. Roni Tamari (66)
  2. Sergio Giralt (46)
  3. Miguel-Angel Perales (41)
  4. Esperanza Papadopoulos (40)
  5. Ann Jakubowski (37)
  6. Sean Devlin (33)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (10)
  4. 2022 (9)
  5. 2021 (6)
  6. 2020 (6)

More Years

Publications
  1. Blood (54)
  2. Blood Advances (12)

Results (66)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation
    Journal Article

    Politikos, I.; Brown, S.; Fein, J. A.; Eng, S.; Casem, K.; Chinapen, S.; Quach, S.; Scaradavou, A.; Cho, C.; Dahi, P.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Prediction of post-transplant relapse of the myelodysplastic syndromes via evaluation of stem cells
    Meeting Abstract

    Kroger, B.; Tamari, R.; Gurnari, C.; Thiebaud, J. A.; Velarde, A. M.; Madanat, Y. F.; Collins, R. H.; Jackson, C.; Gatell, V. I.; Visconte, V.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Phase II study of longitudinal geriatric assessment with risk-adapted interventions to reduce non-relapse mortality in allogeneic hematopoietic cell transplantation for older patients with advanced myeloid malignancies
    Meeting Abstract

    Lin, R. J.; Kim, S. J.; Brown, S.; Hanley, D. M.; Engstler, D. E.; Politikos, I.; Gyurkocza, B.; Tamari, R.; Papadopoulos, E. B.; Saldia, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Long-term follow up of a prospective pilot study of an α/β T-lymphocyte depleted graft conditioned with a reduced intensity regimen in patients with hematologic malignancies
    Meeting Abstract

    Hughes, C. F. M.; Lin, R. J.; Devlin, S. M.; Shaffer, B. C.; Jakubowski, A. A.; Talla, V.; Saldia, A.; Gyurkocza, B.; Papadopoulos, E. B.; Giralt, S. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Efficacy of budesonide monotherapy for low grade GI GVHD after post transplant cyclophosphamide
    Meeting Abstract

    Cook, M.; Vadakkel, G.; Chinapen, S.; Perales, M. A.; Tamari, R.; Papadopoulos, E. B.; Ponce, D. M.; Shaffer, B. C.; Lin, A.
    Blood (2024)

    Fulltext@MSK | Save
  • Clinical Factors but not somatic mutations predict for survival in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplant: Analysis of the North American myelofibrosis transplant outcome (NAMTO) study
    Meeting Abstract

    Ajufo, H.; Derkach, A.; Rampal, R. K.; Famulare, C.; Nemirovsky, D.; Chervin, J.; Ho, V.; Gupta, V.; Viswabandya, A.; Deeg, H. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Optimized double-unit cord blood transplantation mitigates transplant-related mortality resulting in high progression-free survival in adults with hematologic malignancies
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Chinapen, S.; Quach, S.; Dahi, P. B.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Ponce, D. M.; Tamari, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Trem-cel, a CRISPR/Cas9 gene-edited allograft lacking CD33, shows rapid primary engraftment with CD33-negative hematopoiesis in patients with high-risk acute myeloid leukemia (AML) and avoids hematopoietic toxicity during gemtuzumab ozogamicin (GO) maintenance post-hematopoietic cell transplant (HCT)
    Meeting Abstract

    DiPersio, J.; Cooper, B. W.; Suh, H. C.; Koura, D.; Bernard, L.; Shah, N. N.; Walter, R. B.; Perales, M. A.; Mapara, M.; Tamari, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Updated findings of a phase II study of ruxolitinib pre-, during- and post-hematopoietic stem cell transplantation for patients with primary or secondary myelofibrosis
    Meeting Abstract

    Hobbs, G. S.; Kim, H. T.; O'Connor, S.; Schroeder, M. A.; Tamari, R.; Wall, S. A.; El-Jawahri, A.; McAfee, S.; Hem, J.; Lozano, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Topical ruxolitinib for chronic cutaneous GvHD: Promising results of a phase 2 clinical trial
    Meeting Abstract

    Markova, A.; Papadopoulos, E. B.; Dusza, S.; Ostojić, J.; Ai, R.; Maier, T.; Lacouture, M.; Tamari, R.; Gyurkocza, B.; Shaffer, B. C.; more...
    Blood (2023)

    Fulltext@MSK | Save